NovelStem International Corp. (NSTM)
0.0095
0.00 (0.00%)
USD |
OTCM |
Oct 02, 16:00
NovelStem International EPS Diluted (Quarterly) : -0.0017 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.0017 |
| March 31, 2026 | -0.0012 |
| December 31, 2025 | -0.0019 |
| September 30, 2025 | -0.0016 |
| June 30, 2025 | 0.0576 |
| March 31, 2025 | -0.0044 |
| December 31, 2024 | -0.0382 |
| September 30, 2024 | -0.0526 |
| June 30, 2024 | -0.0065 |
| March 31, 2024 | -0.0065 |
| December 31, 2023 | 0.0004 |
| September 30, 2023 | -0.0234 |
| June 30, 2023 | -0.0613 |
| March 31, 2023 | -0.0057 |
| December 31, 2022 | -0.0059 |
| September 30, 2022 | -0.0063 |
| December 31, 2013 | -0.07 |
| September 30, 2013 | 0.36 |
| June 30, 2013 | -0.0019 |
| March 31, 2013 | -0.0127 |
| December 31, 2012 | 0.2076 |
| September 30, 2012 | -0.0999 |
| June 30, 2012 | -0.0567 |
| March 31, 2012 | -0.02 |
| December 31, 2011 | -0.01 |
| Date | Value |
|---|---|
| September 30, 2011 | -0.24 |
| June 30, 2011 | 0.01 |
| March 31, 2011 | -0.06 |
| December 31, 2010 | 0.02 |
| September 30, 2010 | -0.02 |
| June 30, 2010 | 0.00 |
| March 31, 2010 | -0.02 |
| December 31, 2009 | 0.00 |
| September 30, 2009 | -0.03 |
| June 30, 2009 | -0.16 |
| March 31, 2009 | 0.00 |
| December 31, 2008 | -0.21 |
| September 30, 2008 | -0.06 |
| June 30, 2008 | -0.02 |
| March 31, 2008 | -0.10 |
| December 31, 2007 | -0.07 |
| September 30, 2007 | -0.06 |
| June 30, 2007 | -0.04 |
| March 31, 2007 | -0.09 |
| December 31, 2006 | -0.04 |
| September 30, 2006 | -0.06 |
| June 30, 2006 | -0.03 |
| March 31, 2006 | -0.08 |
| December 31, 2005 | -0.04 |
| September 30, 2005 | -0.08 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Brainstorm Cell Therapeutics, Inc. | -0.3494 |
| Summit Therapeutics, Inc. | -0.2772 |
| Kezar Life Sciences, Inc. | -0.7838 |
| Protara Therapeutics, Inc. | -0.3552 |
| Clene, Inc. | -1.084 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.0858M |
| Total Expenses (Quarterly) | 0.0858M |
| Enterprise Value | 2.190M |
| Earnings Yield | -67.37% |
| Normalized Earnings Yield | -68.42 |